The Idaho Board of Pharmacy has issued a regulatory update concerning the over-the-counter (OTC) availability of Ivermectin, referencing Senate Bill 1211. This notice serves to inform stakeholders about the current regulatory landscape for this medication within Idaho.

This update is primarily informational, clarifying the implications of recent legislation on pharmacy practices related to Ivermectin. Regulated entities, particularly pharmacies and healthcare providers, should review the provided memo to understand any changes in dispensing or prescribing requirements. No immediate compliance actions are mandated by this notice, but awareness of the legislative impact is advised.